These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 3105322)

  • 1. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
    Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
    Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
    Winberg CD; Sheibani K; Burke JS; Wu A; Rappaport H
    Cancer; 1988 Oct; 62(8):1539-55. PubMed ID: 2901904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.
    Strauchen JA; Breakstone BA
    Am J Pathol; 1987 Mar; 126(3):506-12. PubMed ID: 3103454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leu-22: a preferential marker for T-lymphocytes in paraffin sections. Staining profile in T- and B-cell lymphomas, Hodgkin's disease, other lymphoproliferative disorders, myeloproliferative diseases, and various neoplastic processes.
    Said JW; Stoll PN; Shintaku P; Bindl JM; Butmarc JR; Pinkus GS
    Am J Clin Pathol; 1989 May; 91(5):542-9. PubMed ID: 2785753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Tac antigen by non-Hodgkin's lymphomas.
    Weiss LM; Michie SA; Medeiros LJ; Strickler JG; Garcia CF; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):483-5. PubMed ID: 2821794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical determination of CD23 expression in Hodgkin's disease using paraffin sections.
    Rowlands DC; Hansel TT; Crocker J
    J Pathol; 1990 Mar; 160(3):239-43. PubMed ID: 2139890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal Involvement by CD30
    Lezama LS; Gratzinger D
    Arch Pathol Lab Med; 2018 Jan; 142(1):139-142. PubMed ID: 29257929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistocytochemical correlation of DAP IV-CD 26 reactivity with immunologic markers of lymphocyte activation in human lymphoid tissues.
    Cozzi M; Gloghini A; Volpe R; Carbone A
    Br J Haematol; 1990 Jul; 75(3):325-32. PubMed ID: 1974815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic and immunologic characterization of 50 peripheral T-cell lymphomas.
    Weiss LM; Crabtree GS; Rouse RV; Warnke RA
    Am J Pathol; 1985 Feb; 118(2):316-24. PubMed ID: 3155915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma.
    Timens W; Visser L; Poppema S
    Lab Invest; 1986 Apr; 54(4):457-61. PubMed ID: 3083157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas.
    Faure GC; Bene MC; Bolle-Chanal MH
    Eur J Haematol; 1987 Jan; 38(1):26-30. PubMed ID: 3034662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.